| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.023 | 0.9 |